chr2-197007889-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001195144.2(ANKRD44):āc.2047A>Gā(p.Ile683Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001195144.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD44 | NM_001195144.2 | c.2047A>G | p.Ile683Val | missense_variant | 20/28 | ENST00000282272.15 | NP_001182073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD44 | ENST00000282272.15 | c.2047A>G | p.Ile683Val | missense_variant | 20/28 | 5 | NM_001195144.2 | ENSP00000282272 | P4 | |
ANKRD44 | ENST00000424317.5 | c.1492A>G | p.Ile498Val | missense_variant | 14/22 | 1 | ENSP00000403415 | |||
ANKRD44 | ENST00000647377.1 | c.2047A>G | p.Ile683Val | missense_variant | 20/28 | ENSP00000496628 | A1 | |||
ANKRD44 | ENST00000328737.6 | c.1972A>G | p.Ile658Val | missense_variant | 20/26 | 2 | ENSP00000331516 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461732Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727184
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.2047A>G (p.I683V) alteration is located in exon 20 (coding exon 20) of the ANKRD44 gene. This alteration results from a A to G substitution at nucleotide position 2047, causing the isoleucine (I) at amino acid position 683 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.